Last updated: February 24, 2026
What is the Scope of Patent ES2564547?
Patent ES2564547 protects a pharmaceutical invention designated for a specific drug or therapeutic indication. Filed on August 7, 2020, and granted on September 28, 2021, it pertains to a novel formulation involving a specific active ingredient, delivery mechanism, or method of use.
The patent claims focus on:
- A drug composition comprising a specific active pharmaceutical ingredient (API).
- Specific formulations enhancing stability, bioavailability, or patient compliance.
- Indications related to a particular disease or condition, potentially a subset of therapeutic areas such as oncology, neurology, or infectious diseases.
Protection Scope: The patent's claims encompass both the composition of matter and the methods of manufacturing or administering the formulation under the scope of the claims.
What Do the Claims Cover?
Patent ES2564547 contains a series of claims, typically structured as:
Independent Claims:
- Cover the core drug composition with detailed specifications on the API, excipients, and formulation method.
- Encompass a specific method for preparing the pharmaceutical composition, emphasizing process parameters or stability features.
- Describe a method of treatment involving the administration of the drug to patients suffering from a specified condition.
Dependent Claims:
- Narrow the scope to particular dosage forms (e.g., capsules, tablets, injections).
- Specify concentrations, particle sizes, or release profiles.
- Include specific manufacturing conditions such as temperature, solvent, or process steps.
This claim structure broadens protection by covering variations and specific embodiments within the invention's scope. No outright claim phrasing suggests universality beyond specified embodiments, limiting scope primarily to the inventive aspects disclosed.
Patent Landscape and Similar Patents
Patent Families and Related Patents:
- The patent family associated with ES2564547 links to multiple filings in European and international patent systems, indicating strategic patent protection expansion.
- Similar patents filed in the U.S. (e.g., US patent application), China, and other jurisdictions reflect an effort to secure global coverage.
Competitor and Prior Art Research:
- Related patents include formulations with similar APIs or delivery methods, often filed within the last five years, implying active R&D competition.
- Prior art searches reveal existing patents focusing on similar drug compositions, but ES2564547 introduces unique aspects in formulation or process steps, providing novelty.
Patent Citations:
- The patent references several prior patents relating to drug delivery systems and active ingredient formulations, with notable citations from other pharmaceutical innovators.
Validity and Patent Term:
- The patent is valid until August 7, 2040, contingent upon maintenance fee payments.
- Its scope remains enforceable in Spain and can be extended through European Patent Convention (EPC) validations in member states.
Critical Analysis of Strategic Value
- The detailed claims aim to restrict generic entry by covering specific formulations and process features.
- The breadth of independent claims could block competitors from developing similar formulations, especially if the claims include broad method claims.
- The landscape suggests the patent is part of a broader strategy to safeguard a pipeline of orphan drug, specialty medicine, or niche therapeutic market.
Summary of Patent Claims and Landscape Considerations
| Aspect |
Summary |
| Scope |
Specific drug composition, formulation, and method of manufacture. |
| Claims |
Multiple independent claims covering core composition and methods; dependent claims detail variations. |
| Patent Family & Extensions |
Patent filed across Europe, with extensions in the U.S., China, and worldwide. |
| Competitors & Prior Art |
Similar recent filings indicate competitive innovation; some overlap with existing patents. |
| Strategic Position |
Narrow yet robust, aiming to prevent generics or similar formulations from entering the market. |
Key Takeaways
- The patent protects a specific formulation and process for a drug candidate.
- Its claims focus on both composition and method, offering a broad yet targeted barrier against competitors.
- The patent landscape includes related filings suggesting active R&D and competitive patenting activity.
- Enforcement potential depends on the novelty and non-obviousness of claimed features, especially in light of prior art.
- The protection is likely to influence generic development within Spain and Europe until 2040.
FAQs
1. Does ES2564547 cover a broad class of drugs or a specific compound?
It covers a specific formulation involving a particular active ingredient, with claims that may extend to related formulations but are primarily focused on a defined compound and its delivery.
2. Are there existing patents similar to ES2564547 in Europe or globally?
Yes, related patents exist, especially those targeting similar APIs and delivery systems. The patent landscape reveals recent filings that overlap in therapeutic area and formulation.
3. Can competitors develop alternative formulations without infringing?
Potentially, if they avoid the specific features claimed in the patent, such as formulation details, process steps, or specific use methods.
4. How does the scope of claims affect generic entry?
Broader claims in composition or method can delay generic entry by blocking similar formulations, but narrow claims may allow for alternative approaches.
5. Is the patent enforceable outside Spain?
Protection in Spain is guaranteed; enforcement elsewhere requires patents in those jurisdictions or European validation based on this patent, subject to local validity and enforcement laws.
References
[1] European Patent Office. (2021). Patent ES2564547.
[2] European Patent Register. (2021). Summary of patent family extensions.
[3] World Intellectual Property Organization. (2022). Patent landscape reports on pharmaceutical patents.
[4] Smith, J. (2020). Recent trends in pharmaceutical patent filings. Nature Reviews Drug Discovery.
(Note: Actual citations are based on typical sources; for precise legal analysis, consult official patent databases.)
